Login / Signup

Editorial comment on "Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long-term safety (TATE study)".

Javier S Cabrera-PerezPhilippe A EigenmannAyobami T Akenroye
Published in: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (2024)
Keyphrases
  • editorial comment
  • chronic obstructive pulmonary disease
  • young adults
  • early onset
  • cystic fibrosis
  • drug induced